Cisplatin clearance
WebJan 7, 2024 · Kidney function was monitored by weekly eGFR and 51 Cr-EDTA clearance measurements; the first measurements were performed prior to receiving any treatment and the comparative measurements were performed after the third treatment with cisplatin. The cisplatin treatment would be discontinued in case of 51 Cr-EDTA clearance decreasing … WebFor research use only. Cisplatin (NSC 119875, Cisplatinum, cis-diamminedichloroplatinum II, CDDP, cis DDP, DDP) is an inorganic platinum complex, which is able to inhibit DNA synthesis by conforming DNA …
Cisplatin clearance
Did you know?
WebNational Center for Biotechnology Information WebJul 22, 2024 · Cisplatin is a potent and valuable chemotherapy agent used to treat a broad spectrum of malignancies. Renal tubular dysfunction and a cumulative impairment in kidney function, as manifested by a decline in the glomerular filtration rate (GFR), can be dose …
WebMean total body clearance was 21 L/h/m 2. Distribution. The initial rapid decline represents distribution to the peripheral compartments and the late (terminal) phase is due, in part, to a relatively slow efflux of docetaxel from the peripheral compartment. Mean steady state volume of distribution was 113 L. ... Cisplatin and Fluorouracil: The ... WebThe effect is dose-dependent at oral doses between 600 and 1800 mg/day in patients with normal kidney clearance. 66 ESRD patients may require higher doses (5 mg) and several studies have provided NAC intravenously to these …
WebDec 16, 2024 · Cisplatin (CDDP; cis-dichlorodiammine platinum [II]) is a non-specific drug of the cell cycle with strong cytotoxicity and broad-spectrum antitumor effects; it is widely used in urogenital system tumors, malignant lymphoma, breast cancer, head and neck cancer, non-small cell lung cancer, etc. ( 1 – 3) Cisplatin-induced nephrotoxicity is … WebApr 15, 2003 · It is noteworthy that cisplatin dose (in the range 70–80 mg m −2) was not associated with nephrotoxicity and that baseline creatinine clearance did not predict for nephrotoxicity (defined as ...
WebSep 21, 2016 · In 25 patients assessable for both courses, the use of a fixed dose of cisplatin resulted in reduced exposure to unbound platinum in patients at the upper extremes of BSA (P = .003) and higher exposures in patients at the lower extremes (P = .009), as compared with exposures following the BSA-adjusted dose.Although clearance …
WebClearance of cisplatin, etoposide, and ifosfamide depends on kidney function and dosages should be adjusted in patients with renal impairment. However, there is still limited data on the adherence of physicians to dosing recommendations for these drugs in cancer patients with renal impairment. tsr consulting warren njWebSep 15, 2024 · Cisplatin is a prescription medicine used to treat the symptoms of cancer in the testicles (Metastatic Testicular Tumors), bladder (Advanced Bladder Cancer) and … tsr conditiontsr control softwareWebSep 21, 2024 · Use of cisplatin therapy is associated with reduced total body clearance. In children, elevated serum SGPT levels are associated with reduced drug total body clearance. Prior use of cisplatin may also … tsr constructsWebALIMTA in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. ... creatinine clearance of ≥ 45 ml/min required no dose adjustments other than those recommended for all patients. There are insufficient data on the use of pemetrexed in patients with ... tsr converseWebCISPLATIN is a chemotherapy drug. It targets fast dividing cells, like cancer cells, and causes these cells to die. This medicine is used to treat many types of cancer like … tsr correlationWebFeb 16, 2024 · This drug should be administered by slow IV infusion. Do not give by rapid IV infusion. Pretreatment hydration with 1 to 2 liters of fluid infused for 8 to 12 hours … phishing scheme e g crossword clue